NCT06087640: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age |
|
|
| Recruiting | 3 | 35800 | Europe, RoW | aQIV or aTIV, Fluad Tetra/Quadrivalent or Fluad, QIV or TIV | Seqirus | Influenza, Human | 11/26 | 12/26 | | |
NCT05210179: Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19 |
|
|
| Completed | 2 | 65 | RoW | TURKOVAC-Dollvet, TURKOVAC-Koçak | Health Institutes of Turkey | COVID-19, Sars-CoV-2 Infection | 02/23 | 05/23 | | |
